The U.S. Food and Drug Administration is notifying health care
professionals and patients that Tyco Healthcare Group LP (Covidien) is
recalling one lot of ReliOn sterile, single-use, disposable, hypodermic
syringes with permanently affixed hypodermic needles due to possible
mislabeling. The use of these syringes may lead to patients receiving an
overdose of as much as 2.5 times the intended dose, which may lead to
hypoglycemia, serious health consequences, and even death.
The recall applies to the following lot number and product information:
-- Lot Number 813900
-- ReliOn 1cc, 31-gauge, 100 units for use with U-100 insulin
We think of many reasons for hypoglycemia when working a diabetic call...but this one wouldn't even be on the radar screen.
The full article:
FDA Reports Nationwide Recall of Mislabeled ReliOn Insulin Syringes